Amsurg Corp. Price Target Increased to $42.00 by Analysts at Piper Jaffray Cos. (AMSG)
Stock analysts at Piper Jaffray Cos. upped their target price on shares of Amsurg Corp. (NASDAQ:AMSG) from $36.00 to $42.00 in a report issued on Thursday, Stock Ratings Network.com reports. The firm currently has a “neutral” rating on the stock. Piper Jaffray Cos.’s price target points to a potential downside of 3.45% from the stock’s previous close.
A number of other analysts have also recently weighed in on AMSG. Analysts at Deutsche Bank raised their price target on shares of Amsurg Corp. from $39.00 to $45.00 in a research note to investors on Wednesday. They now have a “hold” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Amsurg Corp. in a research note to investors on Tuesday, October 15th. They now have a $44.00 price target on the stock. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Amsurg Corp. from $31.00 to $37.00 in a research note to investors on Friday, July 26th. They now have a “hold” rating on the stock.
Amsurg Corp. (NASDAQ:AMSG) traded down 0.05% during mid-day trading on Thursday, hitting $43.50. 131,341 shares of the company’s stock traded hands. Amsurg Corp. has a 52 week low of $25.00 and a 52 week high of $41.00. The stock has a 50-day moving average of $38.93 and a 200-day moving average of $35.71. The company has a market cap of $1.406 billion and a price-to-earnings ratio of 20.14.
Amsurg Corp. (NASDAQ:AMSG) last released its earnings data on Wednesday, October 23rd. The company reported $0.53 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.53. The company had revenue of $268.20 million for the quarter, compared to the consensus estimate of $264.21 million. During the same quarter last year, the company posted $0.49 earnings per share. Amsurg Corp.’s revenue was up 19.3% compared to the same quarter last year. On average, analysts predict that Amsurg Corp. will post $2.20 earnings per share for the current fiscal year.
In other Amsurg Corp. news, EVP Phillip A. Clendenin sold 1,500 shares of Amsurg Corp. stock in a transaction that occurred on Monday, October 21st. The stock was sold at an average price of $43.00, for a total value of $64,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.